Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
111. Vaquero E, Lazzarin N, Valensise H, et al. Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: A comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin. Am J Reprod Immunol 2001; 45: 174.
112. Scott JR, Branch WD, Kochenour NK, Ward K. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol 1988; 159:1055.
113. Spinnato JA, Clark AL, Pierangeli SS, Harris EN. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol 1995; 172: 690.
114. Carp HJA, Asherson RA, Shoenfeld Y. Intravenous immunoglobulin in pregnancies complicated by the antiphospholipid syndrome: what is its role? J Clin Rheumatol 2001; 7: 291—294.
115. Frampton G, Cameron JS, Thom M, et al. Successful removal of antiphospholipid antibody during pregnancy using plasma exchange and low dose prednisolone. Lancet 1987; 2: 1023.
116. Fulcher D, Stewart T, Exner T, et al. Plasma exchange and the anticardiolipin syndrome in pregnancy. Lancet 1989; 2: 171.
117. Denis AL, Guido M, Adler RD, et al. Antiphospholipid antibodies and pregnancy rates
SHS-OOO4.qxd 21.11.2006 16:56 Page 377
77
ГЛАВА 13. Антифосфолипидный синдром: профилактика, лечение и прогноз
and outcome in in vitro fertilization. Fertil Steril 1997; 67:1084.
118. Chilcott IT, Margara R, Cohen H, et al. Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. Fertil Steril 2000; 73: 526.
119. Hornstein MD, Davis OK, Massey JB, et al. Antiphospholipid antibodies and in vitro fetril-ization success: a meta-analysis. Fertil Steril 2000; 73: 330.
120. Lima F, Khamashta MA, Buchanan NM et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheu-matol 1996; 14: 131.
121. Ruffatti A, Dalla Barba T, Del Ross T, et al. Outcome of fifty-five newborns of antiphos-pholipid antibody-positive mothers treated with calcium heparin during pregnancy. Clin Exp Rheumatol 1998; 16: 605.
122. Suarez IM, Diaz RA, Canela DA, de la Llave EP. Correction of severe thrombocytopenia with chloroquine in the primary antiphospholipid syndrome. Lupus 1996; 5: 81.
123. Alarcon-Segovia D, Sanchez-Guerrero, J. Correction of thrombocytopenia with small dose aspirin in the primary antiphospholipid syndrome. J Rheumatol 1989; 16: 1359.
124. Kavanaugh A. Danazol therapy in throm-bocytopenia associated with the antiphospholipid syndrome. Ann Intern Med 1994; 121: 767.
125. Durand JM, Lefevre P, Kaplanski G, et al. Correction of thrombocytopenia with dapsone in the primary antiphospholipid syndrome. J Rheumatol 1993; 20:1777.
126. Ballerini G, Gemmati D, Moratelli S, et al. Anticardiolipin antibody-related thrombocytope-nia: persistent remission after splenectomy. Hematologica 1995; 80: 248—251.
127. Leuzzi RA, Davis GH, Cowchock Fs, et al. Management of immune thrombocytopenic pur-pura associated with the antiphospholipid antibody syndrome. Clin Exp Rheumatol 1997; 15: 197—200.
128. Hakim AJ, Machin SJ, Isenberg DA, Autoimmune thrombocytopenia in primary antiphospholipid syndrome and systemic lupus erythematosus; the response to splenectomy. Semin Arthritis Rheum 1998; 28: 20—25.
129. Galindo M, Khamashta MA, Hughes GRV. Splenectomy for refractory thrombocytope-nia in antiphospholipid syndrome. Rheumatology 1999; 38: 848—853.
130. Font J, Jimenez S, Ververa R, et al. Splenectomy for refractory Evans's syndrome associated with antiphospholipid antibodies: reporet of two cases. Ann Rheum Dis, 2000; 59: 920—923.
131. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest 2001; 119 (Suppl): 132—175.
132. Ahn SS, Kalunian Rosove M, Moore WS. Postoperative thrombotic complications in patients with lupus anticoagulant: increased risk after vascular procedures. Vasc Surg 1988; 7: 749—756.
133. Ciocca RG, Choi J, Graham AM. Anti-phospholipid antibodies lead to increased risk in cardiovascular surgery. Am J Surg 1995; 170: 198—200.
134. Bick RL, Arm B, Frenkel EP. Antiphos-pholipid-thrombosis syndrome, Haemostasis 1999; 29: 100—110.
135. Erkan D, Baleman H, Lockshin MD. Lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythemato-sus; report of 2 cases and review of literature. Lupus 1999; 8: 560—564.
136. Erkan D, Leibowitz E, Berman J, Lock-shin MD. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendation. JRheumatol 2002; 29: 843—849.
137. Gali M, Finazzi G, Barbui T. Thrombo-cytopenia in the antiphospholipid syndrome. Br J Haematol 1996; 93: 1—5.
138. Robertson AJ, Nargund V, Gray DW, Morris PJ. Low dose aspirin as prophylaxis against renal-vein thrombosis in renal transplant recipients. Neprol Dial Transpl 2000; 15: 1865— 1868.
